Bausch+Lomb Results Presentation Deck
2022 Bausch+Lomb Separation Progress¹
Filed Registration Statement and Preliminary Prospectus
for Proposed Initial Public Offering (“IPO”)
Launched Roadshow and IPO
BLCO First Day of Trading (May 6, 2022)
on NYSE and TSX
BLCO is Not a Guarantor of BHC Debt
BHC Announced the Unrestricting of BLCO Under BHC
Debt Covenants (Nov. 29, 2022)
BAUSCH + LOMB
Stanley
lates
+Lomb on
BAUSCH
N
+LOMB
punem votate to these sezamastamise
Sacal11th Comme
better by meens die st
may be cale Morgan
&
e Apes Dup for vinks 2 Fr NY NY S
We understand that Bausch Health continues to believe that the separation of Bausch + Lomb
makes strategic sense and will thoughtfully evaluate all factors related to the Bausch+Lomb separation.
1. The completion of the B+L Separation is subject to a number of factors including receipt of applicable shareholder and other necessary approvals, market conditions and achievement of targeted debt leverage ratios. See Slide 1 for further information regarding forward-looking statements.
6View entire presentation